<?xml version="1.0" encoding="UTF-8"?><add><doc><field name="id">0002568</field><field name="title">[VRGN] STARTS HUMAN TRIALS</field><field name="place">HIALEAH, Fla</field><field name="date">March 11</field><field name="content">- Viragen Inc said it is sponsoring clinical studies of Human Leukocyte Interferon, Alpha, in the treatment of renal cell carcinoma and bladder cell carcinoma.     The Food and Drug Administration approved human trials  will be conducted on at least 30 patients, male and female for each cancer type. </field></doc></add>